Clinical Research Directory
Browse clinical research sites, groups, and studies.
REal World Data in LYmphoma and Survival in Adults
Sponsor: Hospices Civils de Lyon
Summary
REALYSA cohort is a population-based epidemiological platform in real-life for lymphomas designed to enrich prognostic data, by integrating together epidemiological, clinical and biological data. REALYSA is a platform perfectly set up to * Study prognostic factors using integrated epidemiological and biological data (genetics), to better characterize the determinants of refractoriness and relapse in patients with lymphoma, to follow the growing number of survivors and describe median to long-term sequela, second cancer, quality of life (QoL)… * Document treatment effectiveness in real life and observance * Address socio-economical questions
Official title: REAL WORLD DATA IN LYMPHOMA AND SURVIVAL IN ADULTS
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
6000
Start Date
2018-11-14
Completion Date
2027-11-14
Last Updated
2021-06-28
Healthy Volunteers
No
Conditions
Interventions
Real-life epidemiological platform of lymphoma in France
The REALYSA database will be described with the following characteristics: * Number of patients included per month in total and according to subtype of lymphoma * Number of patients in each region in total and according to subtype of lymphoma
Locations (37)
Unité d'Hématologie Clinique, CH D'ARRAS
Arras, France
Service d'Hématologie, CHU Jean Minjoz
Besançon, France
Service d'Onco-radiolothérapie, Polyclinique Bordeaux Nord Aquitaine
Bordeaux, France
Institut Bergonié
Bordeaux, France
Centre Hospitalier Pierre Oudot
Bourgoin, France
Service d'Hématologie, Institut d'Hématologie de Basse Normandie
Caen, France
METROPOLE SAVOIE - SITE CHAMBERY, place Lucien Biset,
Chambéry, France
Service d'Hématologie Clinique et de Thérapie Cellulaire, Hôpital Estaing, CHU de Clermont-Ferrand
Clermont-Ferrand, France
Unité Hémopathies Lymphoïdes, Hôpital Henri Mondor
Créteil, France
CHU Francois MITTERRAND
Dijon, France
Service Hématologie, Centre Hospitalier de Dunkerque
Dunkirk, France
Service Oncologie médicale, Groupe Hospitalier Mutualiste de Grenoble, Institut Daniel Hollard,
Grenoble, France
CHD Vendée
La Roche-sur-Yon, France
Service d'Hématologie Clinique, Centre Hospitalier Universitaire Michallon
La Tronche, France
Clinique Victor Hugo
Le Mans, France
Centre hospitalier Libourne
Libourne, France
Service Oncologie médicale, HOPITAL SAINT VINCENT-DE-PAUL
Lille, France
Service des maladies du sang, Hôpital Claude Huriez, CHRU de Lille
Lille, France
Service Hématologie Clinique et Thérapie Cellulaire, CHU DE LIMOGES - HOPITAL DUPUYTREN,
Limoges, France
Département d'Hématologie et Oncologie, Centre Léon Bérard
Lyon, France
Département d'Hématologie Clinique, Hôpital Saint-Eloi,
Montpellier, France
Service Hématologie, GH REGION MULHOUSE ET SUD ALSACE - HOPITAL EMILE MULLER,
Mulhouse, France
Service d'Hématologie clinique, Centre Hospitalier Universitaire de Nantes
Nantes, France
Centre Hospitalier de Niort
Niort, France
Service Hématologie, Hôpital St Louis
Paris, France
CHU Haut-Lévêque
Pessac, France
Centre Hospitalier Lyon Sud
Pierre-Bénite, France
Service d'Hématologie et Thérapie Cellulaire, Centre Hospitalier Universitaire de Poitiers
Poitiers, France
Hématologie Clinique, CHU PONTCHAILLOU
Rennes, France
Service Hématologie, Centre Hospitalier de Roubaix - Hôpital Victor Provo
Roubaix, France
Service Hématologie, UNIVERSITE DE ROUEN, CENTRE HENRI BECQUEREL
Rouen, France
Service Hématologie, CH YVES LE FOLL
Saint-Brieuc, France
Service Hématologie, Institut Curie - Hôpital René HUGUENIN
Saint-Cloud, France
Département d'Hématologie Clinique et Thérapie Cellulaire, Institut de Cancérologie Lucien Neuwirth
Saint-Priest-en-Jarez, France
Hôpitaux Universitaires de Strasbourg
Strasbourg, France
Institut Universitaire du Cancer
Toulouse, France
Hématologie Clinique, CH DE BRETAGNE ATLANTIQUE
Vannes, France